Universal Health Coverage, Millennium Development Goals And Post-2015: The Improvable Way Forward

Pietro Dionisio TABLE 1 under five mortality rate UN 2015

The negotiating process to achieve post-2015 development goals has clarified the agenda that governments ought to follow until 2030. Unfortunately, due to vague terms and the lack of unequivocal definitions, a number of relevant issues still lie in uncertainty, writes Pietro Dionisio

NGOs Call Out Switzerland For Pressuring Colombia On Compulsory Licences; Switzerland Replies

Glivec

Civil society groups are calling on the Swiss government to refrain from putting pressure on developing countries wishing to manufacture generic medicines without the consent of the patent holder. The groups allege that the Swiss government tried to unduly influence Colombia to not take such a step, though it is permitted by international trade rules.

The Swiss government, for its part, says it participated in a public consultation in Colombia and merely underlined that negotiations between governments and original manufacturers are a better way to go than a compulsory licence.

Australian Review Of IPR, Competition Balance Draws Mixed Academic Response

Australian Productivity Commission

A government-ordered review of Australia’s intellectual property arrangements could either resolve many important and long-standing issues or prove to be yet another political exercise in futility, academics say.

Five Reasons Why TPP Countries Should Unite To Oppose The US Pharmaceutical IP Agenda

Shipping containers. Photo credit: Martin Gleeson

Failure to reach agreement over expanded intellectual property (IP) protections for medicines has proven to be a stumbling block to completion of the 12-country Trans Pacific Partnership negotiations. As expected, the US is continuing to pressure negotiating partners to adopt broader and longer monopoly protections for medicines. But the risks for their health systems are very high – and will be much higher if they don’t stick together in rejecting the US demands.

Finding The Right Balance Between IP And Access To Science

science atoms over book

STRASBOURG – As UN Special Rapporteur Farida Shaheed prepares to finalise a second consecutive report on the connection between the right to science and culture and patent policy, two well-known academics took the floor at the University of Strasbourg Centre for International Intellectual Property Studies (CEIPI) recently to share their views and hopes for this long-awaited paper.

IP-Watch Seeks Part-Time Fundraising/Outreach Expert

ipw-logo-squre

Intellectual Property Watch is seeking a dynamic person to help expand our fundraising and outreach activities.

Medicines Patent Pool At 5 Years: Promises Kept, Changes Ahead – An Interview With Greg Perry

MPPF-LOGO_2_COLORS

The Medicines Patent Pool in Geneva is celebrating five years of existence this month. MPP Executive Director Greg Perry sat down with Intellectual Property Watch Catherine Saez to describe progress made since its inception, the success of its licensing agreement model, and plans for the future, including a possible extension to other diseases such as tuberculosis and hepatitis C.

South Africa Draft Copyright Amendment Bill Published For Public Comment

south_africa_cape_town_table_mountain_12

The publication for public comment of the much-anticipated South African draft Copyright Amendment Bill has cautiously been welcomed by some stakeholders, who believe that parts of the draft are unworkable.

The TPP’s Reckless Proposals For Damages Will Have Negative Impact On Future Reform Of IPR Regimes

Jamie Love

James Love writes: This week negotiators from a dozen countries are meeting to finalize the rules for the Trans Pacific Partnership (TPP) trade agreement. When or if concluded, this massive regional trade agreement will set new standards for the grant of property rights in knowledge, and the enforcement of those rights.

The TPP chapter on intellectual property covers all intellectual property types included in Part II of the WTO’s TRIPS agreement, plus some others, including not only patents, copyrights and trademarks, but also “undisclosed information”, test data for the registration of drugs, industrial designs, layout-designs of integrated circuits. The rules in the TPP are intended by the United States to become global norms, effectively replacing TRIPS.

While there are plenty of issues in the TPP IP Chapter, this note only addresses one set of issues — those relating to the remedies for the infringement of intellectual property rights. The remedies include such topics as injunctions, damages, and the seizure or destruction of infringing goods.

As TPP Ministers Meet, NGOs Make Urgent Push For Public Interest

tpp protests

Trade ministers negotiating the Trans-Pacific Partnership (TPP) agreement meet this week in Maui, Hawaii to try to finish the deal. Along with them are numerous public interest groups strenuously lobbying to steer the deal away from single-minded corporate interest.